GSK grabs Roche veteran and Calico scientist Barron as new R&D head

LONDON (Reuters) - GlaxoSmithKline has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief Executive Emma Walmsley steps up her drive to improve productivity.